GlyNAC as novel nutritional therapeutic for AD

Glynac As Novel Nutritional Therapeutic For Ad enters the Adult Cognitive Disease corpus through the work of Rajagopal Sekhar (submission 141), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Rajagopal Sekhar's submission is summarised in this corpus as:

Alzheimer's disease is caused by severe defects in energy metabolism driven by deficiency of glutathione (GSH) and its precursor amino acids glycine and cysteine. This GSH deficiency triggers a cascade of mitochondrial dysfunction, oxidative stress, insulin resistance, endoplasmic reticulum stress, impaired autophagy, cellular senescence, inflammation, and genomic damage, all correctable by GlyNAC supplementation.

Where it sits

The submission scores against the framework's convergence nodes as: compensatory paradigm 4 · neuroimmune interface 3.

Its declared subject matter: glutathione deficiency, GlyNAC, oxidative stress, mitochondrial dysfunction, energy metabolism, insulin resistance, nutritional intervention, brain glucose.

Named by the same submission

4 other concepts enter the corpus through the same paper, so they cover adjacent ground: Brain-glucose-steal as mechanism of cognitive impairment · Energy metabolism failure drives neurodegeneration · GSH deficiency as root cause of multiple AD defects · Cellular Senescence.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.